proteome profiler antibody based angiogenesis array (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
96
Structured Review
R&D Systems
proteome profiler antibody based angiogenesis array
Proteome Profiler Antibody Based Angiogenesis Array, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 389 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+array/Proteome+Profiler+Human+Angiogenesis+Array+Kit/pmc05495564-107-0-6
Average 96 stars, based on 389 article reviews
Proteome Profiler Antibody Based Angiogenesis Array, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 389 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+array/Proteome+Profiler+Human+Angiogenesis+Array+Kit/pmc05495564-107-0-6
Average 96 stars, based on 389 article reviews
proteome profiler antibody based angiogenesis array - by Bioz Stars,
2026-10
96/100 stars
Images
1) Product Images from "Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy"
Article Title: Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy
Journal: PLoS ONE
doi: 10.1371/journal.pone.0180297
Figure Legend Snippet: A, Bazedoxifene inhibits tube formation. HUVECs were seeded on Matrigel-coated wells with VEGF (10 ng/ml) in the absence or in the presence of Bazedoxifene and incubated for 24 hours to form a capillary network. The total number of branched tubes was then counted and representative image of capillary network formation was taken. B, Bazedoxifene downregulates several angiogenic factors in vitro . The proteome profiler antibody angiogenesis array was performed. The relative level of selected angiogenesis-related proteins was determined in parallel between untreated (left) and treated (right) HUVEC cells. C, Bazedoxifene inhibits endothelial cellular invasion. HUVECs (1 × 10 6 cells/ml) were added to transwell chamber coated with Matrigel and treated with VEGF (20 ng/ml) in the absence or in presence of Bazedoxifene. After 24 hours, the number of invaded cells was counted, and results are expressed as percentage of invasion (basal invasion with no treatment). D, Bazedoxifene blocks rhabdomyosarcoma cells invasion. Parental RH30 and RH28 cells were starved in 0% FBS medium for 24 hours. After that, cells were seeded (5 × 10 4 cells/well) to the top chamber, and 10% FBS was added into the lower chamber. Cells were treated with Bazedoxifene for 24 hours, and then invasion cells were detected in the bottom chamber using a Cultrex BME Cell Invasion Assay. Statistical analysis of three independent experiments was shown as means, *, P < 0.05.
Techniques Used: Incubation, In Vitro, Invasion Assay
Related Articles
other:Article Title: Telocyte-derived pentraxin 3 enables vascular pruning as a key driver in infantile hemangioma regression. Article Snippet: were cultivated for 48 h in cytokine-free ECGM2 but supplemented with 1% FBS. Supernatants were collected, centrifuged for 10 min (3,500 rpm) and were screened using the Angiogenesis Profiler array ( |
